Role evidence
Usage summary
Strongest role: Treatment Assignment
Inclusion-required count: 0
Treatment-assignment count: 1
Stratification count: 0
Low Public Signal
KRAS G12D
solid tumor basket · Monoclonal Antibody
KRAS G12D is flagged as low public signal because public trials show treatment assignment evidence in 2 contexts. FDA CDx context should be reviewed manually.
Threshold snippets
Fragmentation view
Threshold count: 1
Common snippets: dMMR
Threshold label: Low
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT04589845 | https://clinicaltrials.gov/study/NCT05631899